Comments on: EC approves AstraZeneca and Merck’s Lynparza for two cancer types /news/ec-astrazeneca-merck-lynparza/ The leading site for news and procurement in the pharmaceutical industry Fri, 02 Dec 2022 15:08:16 +0000 hourly 1 https://wordpress.org/?v=6.6.2